Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
IASO study team
Division of Infectious Diseases
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Rheumatic Diseases Research Resource-Based Center
COVID-19 Researchers
DBBS - Immunology
DBBS - Molecular Microbiology and Microbial Pathogenesis
Brain Tumor Center
Research output
:
Contribution to journal
›
Article
›
peer-review
190
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
SARS-CoV-2 Omicron
100%
Omicron BA.2
100%
BA.2
100%
Antiviral Susceptibility
100%
Pathogenicity
57%
Therapeutic Monoclonal Antibody
57%
BA.1
57%
Hamster
42%
Antiviral Drugs
28%
COVID-19
28%
SARS-CoV-2 Strains
28%
Recombinant
14%
Rodents
14%
Viral Infection
14%
Neutralizing Activity
14%
Infectivity
14%
Antiviral Compounds
14%
Respiratory Organs
14%
Spike Protein
14%
Variant Strain
14%
Human ACE2
14%
REGN10987
14%
REGN10933
14%
Delta Variant
14%
ACE2-expressing Mice
14%
Omicron BA.1
14%
Omicron Lineages
14%
COVID Vaccine
14%
Nirmatrelvir
14%
S-217622
14%
Molnupiravir
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Pathogenicity
100%
SARS Coronavirus
100%
Monoclonal Antibody
75%
Antiviral Drug
75%
Infection
25%
Virus Infection
25%
Therapeutic Vaccine
25%
Delta Variant
25%
Molnupiravir
25%
Nirmatrelvir
25%
Immunology and Microbiology
Nirmatrelvir
25%